Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Plasmodium digestive vacuole (DV), also known as the food vacuole, is a specialized acidic organelle essential for the survival of malaria parasites during their intraerythrocytic stage (Wunderlich et al., 2012). Its primary biological function is the degradation of host hemoglobin to provide a source of amino acids for parasite protein synthesis (Goldberg, 2005). A critical byproduct of this proteolysis is the release of toxic free heme (ferriprotoporphyrin IX), which the parasite detoxifies by converting it into an insoluble crystalline polymer known as hemozoin (Egan, 2008). This organelle is the primary site of action for several classes of antimalarial drugs, most notably the quinolines like chloroquine and quinine, which interfere with the heme detoxification process (Sullivan, 2002). Inhibition of hemozoin formation leads to the accumulation of free heme, which causes oxidative damage to parasite membranes and ultimately results in parasite death (Combrinck et al., 2013). Additionally, the DV membrane contains transporters such as the Plasmodium falciparum chloroquine resistance transporter (PfCRT), which plays a central role in drug resistance by mediating the efflux of drugs away from their site of action (Roepe, 2011).
Inhibition of heme biocrystallization (hemozoin formation), leading to the accumulation of toxic free heme (ferriprotoporphyrin IX) which causes oxidative damage and membrane lysis within the parasite (Egan, 2008; Sullivan, 2002). Some drugs also inhibit vacuolar proteases or disrupt the organelle's pH gradient (rxlist.com).
8 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Plasmodium digestive vacuole (DV).